Nightfood Holdings Inc. (NGTF) Offers Automation Robotics Solutions to Labor Shortages, Slow Service, Lost Sales

Nightfood Holdings Inc. (NGTF) Offers Automation Robotics Solutions to Labor Shortages, Slow Service, Lost Sales GlobeNewswire February 03, 2026 NEW YORK, Feb. 03, 2026 (GLOBE NEWSWIRE) — via AINewsWire — Nightfood Holdings inc. (NGTF) today announces its placement in an editorial published by AINewsWire (“AINW”), one of 75+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrandNetwork), […]

HOOKIPA Pharma Announces Sale of Oncology Assets to NeoTrail Therapeutics

HOOKIPA Pharma Announces Sale of Oncology Assets to NeoTrail Therapeutics Next-generation therapeutic cancer vaccines in development for various oncology indications sold to NeoTrail Therapeutics with an undisclosed purchase price GlobeNewswire February 03, 2026 NEW YORK and VIENNA, Austria, Feb. 03, 2026 (GLOBE NEWSWIRE) — HOOKIPA Pharma Inc. (OTCID: HOOK, “HOOKIPA”, the “Company”) today announced the

Jayud Global Logistics Certified as Alibaba Verified Supplier

Jayud Global Logistics Certified as Alibaba Verified Supplier GlobeNewswire February 03, 2026 SHENZHEN, China, Feb. 03, 2026 (GLOBE NEWSWIRE) — Jayud Global Logistics Limited (NASDAQ: JYD) (“Jayud” or the “Company”), a leading end-to-end supply chain solutions provider based in Shenzhen that specializes in cross-border logistics, today announced that it has been officially certified as a

Champion Safe Company Notes Strong Year-Over-Year Order Growth from Heavy Metal Gun Safes

Champion Safe Company Notes Strong Year-Over-Year Order Growth from Heavy Metal Gun Safes GlobeNewswire February 03, 2026 Heavy Metal Gun Safes Records Over 56% Year-Over-Year Growth in Champion Safe Orders from 2024 to 2025 Provo, UT, Feb. 03, 2026 (GLOBE NEWSWIRE) — Champion Safe Company (championsafe.com), a premier manufacturer of high-security safes and a proud

GT Biopharma Announces FDA Clearance of Investigational New Drug (IND) Application for GTB-5550 TriKE(R), a B7-H3-Targeted Natural Killer (NK) Cell Engager for Solid Tumors Expressing B7-H3

GT Biopharma Announces FDA Clearance of Investigational New Drug (IND) Application for GTB-5550 TriKE(R), a B7-H3-Targeted Natural Killer (NK) Cell Engager for Solid Tumors Expressing B7-H3 GlobeNewswire February 03, 2026 GTB-5550 Phase 1 dose escalation basket trial expected to initiate mid-2026 Phase 1 protocol allows multiple solid tumor types known to express B7-H3 Unaudited proforma

Percepta Announces Leadership Transition as President Karen Gurganious Steps Down; TTEC Executive Thomas Monaghan Named Successor

Percepta Announces Leadership Transition as President Karen Gurganious Steps Down; TTEC Executive Thomas Monaghan Named Successor GlobeNewswire February 03, 2026 DEARBORN, Mich., Feb. 03, 2026 (GLOBE NEWSWIRE) — Percepta, a global customer experience (CX) company and joint venture between TTEC Holdings, Inc. (TTEC) and Ford Motor Company, today announced that President Karen Gurganious has stepped

Beeline to Integrate Its Digital Quality Control Platform, BLINKQC, Into Encompass Platform, Expanding Access to Over 3,100 Mortgage Lenders

Beeline to Integrate Its Digital Quality Control Platform, BLINKQC, Into Encompass Platform, Expanding Access to Over 3,100 Mortgage Lenders Collaboration with Stellar Innovation and Integration with ICE Mortgage Technology's Encompass(R) System, Expands BLINKQC's Presence GlobeNewswire February 03, 2026 PROVIDENCE, R.I., Feb. 03, 2026 (GLOBE NEWSWIRE) — via IBN – Beeline Holdings (NASDAQ: BLNE), a fast-growing

Skyward Specialty Launches New Power Generation Coverage Solution

Skyward Specialty Launches New Power Generation Coverage Solution GlobeNewswire February 03, 2026 HOUSTON, Feb. 03, 2026 (GLOBE NEWSWIRE) — Skyward Specialty Insurance Group, Inc.(R), a Skyward Group Company, (Nasdaq: SKWD) (“Skyward Specialty” or “the Company”), a leading provider in the specialty property and casualty (P&C) insurance market, announced the launch of its new specialized Power

Oragenics Partners with DUCK FLATS Pharma to Support FDA IND Readiness and Clinical Trial Design for Concussion Program

Oragenics Partners with DUCK FLATS Pharma to Support FDA IND Readiness and Clinical Trial Design for Concussion Program GlobeNewswire February 03, 2026 Collaboration reinforces regulatory diligence, nonclinical strategy and clinical trial integrity for novel intranasal concussion therapy Traumatic brain injuries affect more Americans each year than stroke, Alzheimer's disease, Parkinson's disease, multiple sclerosis, and ALS

ETQ Recognized as a Leader in the Gartner(R) Magic Quadrant(TM) for Quality Management System Software 2026

ETQ Recognized as a Leader in the Gartner(R) Magic Quadrant(TM) for Quality Management System Software 2026 Recognition based on “Completeness of Vision and Ability to Execute” GlobeNewswire February 03, 2026 BURLINGTON, Mass., Feb. 03, 2026 (GLOBE NEWSWIRE) — ETQ, part of Hexagon, today announced that it has been positioned by Gartner as a Leader in

Scroll to Top